Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

ECL-based Infectious Pathogen (bio)SEnsor

Project description

Innovative technology for fast and reliable pathogen detection

The threat of infectious diseases and recent pandemics has highlighted the urgent need for novel, fast, cheap, simple and reliable pathogen detection tools. The EU-funded ECLIPSE project aims to develop a new technological platform for pathogen detection. A phage-sandwich method will be used for detection of the whole pathogen and the surface cooperative hybridisation technique for detection of microbial and viral nucleic acids. Combined with electrochemiluminescence, this will grant the novel technology high affinity, selectivity and reliability. The objective is to prove the feasibility and adaptability of platform detection in the test cases of the SARS-CoV-2 virus, Pseudomonas bacterium, and Leishmania protozoan parasite. The platform design allows rapid adaptation for the detection of other pathogens and (future/coming) pandemic agents.

Objective

"Infectious diseases are a threat to mankind since their appearance in human history. Despite the advances in science and technologies, such threats are still recurrent, as recently shown by the COVID-19 pandemic in 2020 – 2021, which has revealed the urgent need for novel tools for pathogen detection that would be at the same time reliable, fast, cheap, portable and simple. The goal of ECLIPSE is to address this need, with a new platform exploiting innovative ultrasensitive protocols for the detection of pathogens. ECLIPSE builds on the combination of interdisciplinary elements to facilitate the transfer to industry, i.e. (i) ElectroChemiLuminescence (ECL) as a very sensitive transduction mechanism for realizing simple, portable and cheap devices, (ii) bio-, nano-, and supramolecular-based signal amplification structures for increasing the sensitivity, and (iii) two recognition strategies to afford high affinity and selectivity, thus leading to high reliability: the Phage-Sandwich technology for the whole pathogen, and the Surface Cooperative Hybridization technology for microbial and viral nucleic acid. We will demonstrate the feasibility and adaptability of the ECLIPSE platform with three test cases: a virus (SARS-CoV-2), a bacterium (Pseudomonas aeruginosa) and a protozoan parasite (Leishmania infantum). The platform is designed to be applied to many other infectious agents, making it a ""ready for the next pandemic” technology. ECLIPSE is expected to become a game-changer in European countries, where it could be a cornerstone for fast testing and reliable tracking of infections, and in developing countries that will benefit from a cheap and simple approach to detect the many infectious diseases that affect millions of people every year. The project results will be validated and demonstrated at partners’ premisses."

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-EIC - HORIZON EIC Grants

See all projects funded under this funding scheme

Call for proposal

(opens in new window) HORIZON-EIC-2021-PATHFINDEROPEN-01

See all projects funded under this call

Coordinator

ALMA MATER STUDIORUM - UNIVERSITA DI BOLOGNA
Net EU contribution
€ 819 234,75
Address
VIA ZAMBONI 33
40126 Bologna
Italy
Region
Nord-Est Emilia-Romagna Bologna
Activity type
Higher or Secondary Education Establishments
Links
Total cost
€ 833 421,25

Participants (8)

Partners (1)